Cell lines with stronger Sprouty4 expression (i.e., MCF10.DCIS, MCF10.CA1d/S1 and MCF10.CA1d/S2) exhibited lower levels of Slug, suggesting that active ERK1/2 signaling was also lower (see Fig 2). The gene discussed is MAPK3; the disease is ductal breast carcinoma in situ.